Tag: AMERS
Wall Street ends lower, pausing rally as Powell testimony looms
U.S. stocks softened on Tuesday, closing in negative territory as investors began the holiday-shortened week by taking profits in the wake of a sustained rally amid signs of weakening global demand.
YouTube CEO Wojcicki, one of the first Google employees, steps down
YouTube Chief Executive and one of the first Google employees, Susan Wojcicki, is stepping down from her role at the tech giant that started in her garage nearly 25 years ago, she said in a personal update on the video-sharing platform on Thursday.
Ford halts F-150 EV production, deliveries after battery fire
Ford Motor Co on Wednesday said the suspension of production of its F-150 Lightning electric vehicle (EV) will last until at least the end of next week after a battery fire involving one of the vehicles earlier in the month.
Elon Musk says end-2023 'good timing' to find new Twitter head
Twitter Chief Executive Elon Musk said on Wednesday that towards the end of 2023 would be "good timing" to find someone else to run Twitter, when he expects the social media platform to be stable.
Italy warns hackers targeting known server vulnerability
Thousands of computer servers around the world have been targeted by a ransomware attack, the country's National Cybersecurity Agency said, warning organizations to protect their systems.
Tesla's Elon Musk found not liable in trial over 2018 'funding secured' tweets
A U.S. jury on Friday found Tesla Inc CEO Elon Musk and his company were not liable for misleading investors when Musk tweeted in 2018 that he had "funding secured" to take the electric car company private.
Musk bullish on Tesla sales as price cuts boost demand
Tesla Inc's aggressive price cuts have ignited demand for its electric vehicles, Chief Executive Elon Musk said on Wednesday, playing down concerns that a weak economy would throttle buyers' interest.
Spotify to trim 6% of workforce in latest tech layoffs
Spotify Technology SA said on Monday it plans to cut 6% of its workforce and would take a related charge of up to nearly $50 million, adding to the massive layoffs in the technology sector in preparation for a possible recession.
Alphabet cuts 12,000 jobs after pandemic hiring spree, refocuses on AI
The job cuts affect 6% of the Google parent's workforce, and follow thousands of layoffs at tech giants who are downsizing after a pandemic-led hiring spree left them flabby in a weak economy.
Brazil and Argentina to discuss common currency
Brazil and Argentina aim for greater economic integration, including the development of a common currency, Brazilian President Luiz Inacio Lula da Silva and Argentine leader Alberto Fernandez said in a joint article they penned.
U.S. officials advise Ukraine to wait on offensive, official says
Senior U.S. officials are advising Ukraine to hold off on launching a major offensive against Russian forces until the latest supply of U.S. weaponry is in place and training has been provided, a senior Biden administration official said on Friday.
Davos 2023: Greta Thunberg accuses energy firms of throwing people 'under the bus'
Greta Thunberg called on the global energy industry and its financiers to end all fossil fuel investments on Thursday at a high-profile meeting in Davos with the head of the International Energy Agency (IEA).
China's first population drop in six decades sounds alarm on demographic crisis
China's population fell last year for the first time in six decades, a historic turn that is expected to mark the start of a long period of decline in its citizen numbers with profound implications for its economy and the world.
Microsoft faces EU antitrust warning over Activision deal - sources
Microsoft is likely to receive an EU antitrust warning about its $69 billion bid for "Call of Duty" maker Activision Blizzard , people familiar with the matter said, that could pose another challenge to completing the deal.
Eisai, Biogen receives U.S. FDA approval for Alzheimer's drug, applies for full approval
The drug aims to slow the advance of the neurodegenerative disease. Nearly all previous experimental drugs using the same approach have failed.